Live feed
Filing
SC 13G/A
SC 13G/A0000921895-18-002043·BIOTECHNOLOGY VALUE FUND L P
Schedule 13G ownership disclosure
Erytech Pharma S.A.
Security class unavailable · CUSIP: 29604W108
Event date: 2018-06-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-18-002043
- Form type
- SC 13G/A
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Jul 02, 2018
- Reporting period
- Jun 28, 2018
- Description
- Schedule 13G beneficial ownership